Skip to main content
. 2016 May 27;7(27):41758–41766. doi: 10.18632/oncotarget.9676

Figure 1.

Figure 1

Comparison of serum haptoglobin levels (A) between normal healthy controls and NSCLC patients; (B) in normal healthy controls and NSCLC patients at different TNM stage; (C) in NSCLC patients with and without lymph node metastasis; (D) in NSCLC patients with and without distant metastasis.